Magnetic therapy equipment and magnetic therapy system

Abstract

The utility model provides magnetic therapy equipment and a magnetic therapy system. The magnetic therapy equipment is used for carrying out magnetic therapy on a user, and comprises a supporting assembly; the magnetic therapy device comprises a supporting assembly and a magnetic therapy assembly, the magnetic therapy assembly is borne by the supporting assembly, the magnetic therapy assembly comprises a bearing plate, and the bearing plate is connected to the supporting assembly; the cushion is arranged on the side, away from the supporting assembly, of the bearing plate and borne by the bearing plate, the cushion and the bearing plate jointly form a containing space, and the cushion is used for bearing a user; the magnetic generation assembly is arranged in the containing space, the magnetic generation assembly comprises a coil, the coil is arranged right opposite to the cushion, and the coil is used for generating a magnetic field when powered on so as to perform magnetic therapy on a user through the magnetic field. When the magnetic therapy equipment is used for treating haemorrhoids, the infection risk in the haemorrhoids treatment process can be reduced, and the safety of haemorrhoids treatment is improved.

Description

Technical Field

[0001] This application relates to the field of magnetic therapy equipment technology, specifically to a magnetic therapy device and magnetic therapy system. Background Technology

[0002] Hemorrhoids are one of the most common anal diseases in clinical practice. Hemorrhoids are pathological enlargements of the anal cushions at the lower end of the rectum. Depending on the location, hemorrhoids can be divided into internal hemorrhoids, external hemorrhoids, and mixed hemorrhoids.

[0003] Currently, electrostimulation therapy is one of the rehabilitation treatments for hemorrhoids. However, electrostimulation therapy has disadvantages such as being invasive, unhygienic, and uncomfortable. In addition, there is a risk of infection from multiple patients sharing the electrode heads. Furthermore, the treatment probe itself, which is inserted into the body for a long time during the procedure, can easily cause damage or infection to the body cavity. Therefore, the problem of how to provide a hemorrhoid treatment device with low infection risk urgently needs to be solved. Utility Model Content

[0004] This application provides a magnetic therapy device and system for treating hemorrhoids with a low risk of infection.

[0005] In a first aspect, this application provides a magnetic therapy device for performing magnetic therapy on a user, the magnetic therapy device comprising:

[0006] Support components; and

[0007] A magnetic therapy component, which is supported by the support component, includes:

[0008] A support plate, which is connected to the support assembly;

[0009] A seat cushion is disposed on the side of the support plate opposite to the support assembly and supported by the support plate. The seat cushion and the support plate together form a receiving space, and the seat cushion is used to support the user.

[0010] A magnetic generation component is disposed within the receiving space. The magnetic generation component includes a coil positioned directly opposite the seat cushion. The coil is used to generate a magnetic field when energized, so as to provide magnetic therapy to the user through the magnetic field.

[0011] The magnetizing component includes: a control circuit, an adjustable pulse power supply, an RC circuit, a MOSFET switching circuit, an RLC oscillation circuit, a frequency adjustment module, a magnetic field feedback module, and a physiological parameter detection module. The RLC oscillation circuit includes the coil.

[0012] The first terminal of the control circuit is connected to the first terminal of the frequency adjustment module; the second terminal of the control circuit is connected to the first terminal of the adjustable pulse power supply; the third terminal of the control circuit is connected to the first terminal of the magnetic field feedback module; the fourth terminal of the control circuit is connected to the physiological parameter detection module; the second terminal of the frequency adjustment module is connected to the first terminal of the MOSFET switching circuit; the second terminal of the magnetic field feedback module is connected to the third terminal of the RLC oscillation circuit; the second terminal of the adjustable pulse power supply is connected to the first terminal of the RC circuit; the second terminal of the RC circuit is connected to the fourth terminal of the MOSFET switching circuit; the second terminal of the MOSFET switching circuit is connected to the first terminal of the RLC oscillation circuit; the third terminal of the MOSFET switching circuit is connected to the second terminal of the RLC oscillation circuit; the third terminal of the RLC oscillation circuit is connected to the second terminal of the magnetic field feedback module.

[0013] The RLC oscillation circuit further includes: a first resistor and a first capacitor. The first end of the first resistor is connected to the second end of the MOSFET switching circuit as the first end of the RLC oscillation circuit. The second end of the first resistor is connected to the first end of the coil. The second end of the coil is connected to the second end of the first capacitor. The second end of the coil is also connected to the second end of the magnetic field feedback module as the third end of the RLC oscillation circuit. The first end of the first capacitor is connected to the third end of the MOSFET switching circuit as the second end of the RLC oscillation circuit.

[0014] The support plate and the seat cushion are spaced apart to form the receiving space, and the magnetizing component is disposed between the support plate and the seat cushion, with the magnetizing component spaced apart from both the support plate and the seat cushion.

[0015] The magnetic therapy component further includes a first support member, which is disposed within the receiving space and connected to the cushion or support plate.

[0016] The magnetizing assembly further includes a coil holder, the coil is disposed in the coil holder, and the coil holder is connected to the first support member, so that the magnetizing assembly is suspended between the support plate and the cushion.

[0017] The coil holder includes a supporting part, a limiting part, and a connecting part. The limiting part extends from the outer periphery of the supporting part toward the supporting plate and toward the seat cushion. The supporting part and the limiting part together form an accommodating space for accommodating the coil. The connecting part is connected to the supporting part or the limiting part and is fixedly connected to the first support member so as to support the magnetizing component through the first support member.

[0018] The magnetic therapy component also includes a fan, which is disposed within the containment space and faces the magnetic generating component. The fan is used to increase the airflow speed within the containment space.

[0019] The magnetic therapy component further includes a second support member, the opposite ends of which are connected to the support plate and the seat cushion, respectively, so that the support plate and the seat cushion are spaced apart.

[0020] The magnetic therapy device also includes a backrest, which is connected to the magnetic therapy component or the support component. The backrest is arranged along the periphery of the magnetic therapy component for the user to lean against.

[0021] The magnetic therapy device also includes a housing, which is arranged circumferentially around the magnetic therapy component and encloses the magnetic therapy component and the backrest.

[0022] The support component includes a motor and a base. The motor is supported on the base, and one end of the motor away from the base is connected to the magnetic therapy component. The motor is used to drive the magnetic therapy component away from or towards the base in the relative direction between the support plate and the cushion.

[0023] Secondly, this application also provides a magnetic therapy system, which includes a host computer and the aforementioned magnetic therapy device, wherein the host computer is used to control the magnetic therapy device to generate a magnetic field.

[0024] The magnetic therapy device provided in this application includes a magnetic therapy component comprising a support plate, a seat cushion, and a magnetic generating component. The coil of the magnetic generating component is positioned directly opposite the seat cushion and generates a magnetic field when energized. Therefore, when a user sits on the seat cushion, the magnetic field generated by the coil acts on the user, providing magnetic therapy and thus improving hemorrhoid problems. It is understood that using this magnetic therapy device to treat hemorrhoids requires only that the user sit on the device; no complicated operation is needed, and the device does not need to be inserted into the body, thus avoiding damage or infection to body cavities. This reduces the risk of infection during hemorrhoid treatment, improves the safety of hemorrhoid treatment, and also alleviates the pain caused by hemorrhoids. In other words, this application provides a low-infection-risk magnetic therapy device and system for treating hemorrhoids. Furthermore, since the coil is housed within the containment space formed by the seat cushion and the support plate, the coil is protected and external objects are isolated to a certain extent, preventing external objects from affecting the magnetic field and weakening the magnetic therapy effect. Attached Figure Description

[0025] To more clearly illustrate the technical solutions of the embodiments of this application, the drawings used in the implementation will be briefly introduced below. Obviously, the drawings described below are some implementations of this application. For those skilled in the art, other drawings can be obtained from these drawings without creative effort.

[0026] Figure 1 A schematic diagram of the magnetic therapy device provided in the embodiments of this application.

[0027] Figure 2 for Figure 1 An exploded view of the magnetic therapy device shown.

[0028] Figure 3 for Figure 2 The diagram shows a partial composition of the magnetic therapy components in the magnetic therapy device.

[0029] Figure 4 for Figure 3 An exploded view of the magnetic therapy components shown.

[0030] Figure 5 The circuit structure diagram of the magnetizing component provided in the embodiments of this application is shown.

[0031] Figure 6 An exploded view of the seat cushion provided in an embodiment of this application.

[0032] Figure 7 for Figure 3 The magnetic therapy assembly shown is a cross-sectional view along line AA.

[0033] Figure 8 This is a schematic diagram of a coil holder provided in an embodiment of this application.

[0034] Figure 9 A schematic diagram showing a fan included in a magnetic therapy component provided in an embodiment of this application.

[0035] Figure 10 for Figure 2 A schematic diagram of the backrest in the magnetic therapy device shown.

[0036] Figure 11 This is a schematic diagram of a magnetic therapy component provided in another embodiment of this application.

[0037] Figure 12 A schematic diagram of the magnetic therapy system provided in the embodiments of this application.

[0038] Figure 13 This is a diagram showing the electrical connection between the host and the magnetic therapy device provided in an embodiment of this application.

[0039] Figure 14 for Figure 12The diagram shows a schematic of the main unit of the magnetic therapy system from a first-view perspective.

[0040] Figure 15 for Figure 12 The diagram shows the main unit of the magnetic therapy system from another perspective.

[0041] Explanation of icon numbers:

[0042] Magnetic therapy system 1; magnetic therapy device 10; support component 11; magnetic therapy component 12; backrest 13; outer shell 14; motor 111; base 112; surrounding panel 113; support plate 121; seat cushion 122; magnetic generation component 123; first support member 124; fan 125; second support member 126; indicator light 127; hard layer 1221; first soft layer 1222; magnetic field permeable plate 1223; coil 1231; coil seat 1232; support part 1232a; receiving space X1; accommodating space X2; through hole X3; through hole X4; limiting part 1232b; connecting part 1232c; main unit 20; controller 21; control panel 22; camera 23; button 24; support body 25; base 26; push handle 27; base body 261; roller 262.

[0043] Appendix to this application Figure 5 In the diagram, the letters near the module (circuit) connections indicate the port numbers (in alphabetical order to indicate port number size), for example, Figure 5 The letter 'a' on the top of the control circuit indicates the first terminal of the control circuit, the letter 'b' on the right side of the control circuit indicates the second terminal of the control circuit, and so on. Detailed Implementation

[0044] The technical solutions of the embodiments of this application will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of this application, and not all embodiments. Based on the embodiments of this application, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the scope of protection of this application.

[0045] In this document, references to "embodiment" or "implementation" mean that a particular feature, structure, or characteristic described in connection with an embodiment or implementation may be included in at least one embodiment of this application. The appearance of this phrase in various places throughout the specification does not necessarily refer to the same embodiment, nor is it a separate or alternative embodiment mutually exclusive with other embodiments. It will be explicitly and implicitly understood by those skilled in the art that the embodiments described herein can be combined with other embodiments.

[0046] Hemorrhoids are a common anorectal disease that causes considerable inconvenience and distress to patients' lives and work. Current treatment methods for hemorrhoids mainly include medication, surgery, and electrostimulation therapy. Traditional medication has drawbacks such as systemic adverse reactions and side effects, unstable efficacy, and low cure rates. Surgical treatment is painful, and postoperative bowel movements can accidentally tear and infect the sutures. Electrostimulation therapy is invasive, unhygienic, and uncomfortable, and carries the risk of infection from shared electrode heads. The long-term placement of the treatment probe within the body can also damage or infect body cavities. The procedure is complex, difficult for patients to accept, and can cause pain, ultimately worsening the condition and failing to achieve the desired therapeutic effect. However, magnetic therapy for hemorrhoids only requires the user to sit on the device; no complicated operation or insertion of the device into the body is needed, eliminating the risk of infection within body cavities and improving the safety of hemorrhoid treatment. It can also alleviate the pain associated with hemorrhoids. The following are some experimental data on the treatment of hemorrhoids using electrical stimulation and magnetotherapy:

[0047] Electrical stimulation therapy for hemorrhoids:

[0048] Experimental Data: Treatment of Internal and Mixed Hemorrhoids with Type A-I Electrotherapy Machine: 100 patients received treatment with the Type A-I electrotherapy machine. All patients reported a reduction in pain levels compared to before treatment, meaning the effective rate was 100%. 72 patients experienced significant reduction in hemorrhoid swelling, resulting in an excellent and good rate of 72%. The current intensity during treatment was mostly 12mA-16mA, with a treatment time of 5-10 minutes. Most hemorrhoids could be treated in one session, while some large hemorrhoids required multiple treatments.

[0049] Advantages: The treatment effect is relatively good. Most patients experience significant improvement in symptoms after treatment, such as a substantial reduction in hemorrhoid bleeding and pain. The recurrence rate is relatively low, approximately 10%-20%.

[0050] Disadvantages: It has disadvantages such as being invasive, unhygienic, and uncomfortable. There is also a risk of infection from multiple patients sharing the electrode head. The treatment probe, which is inserted into the body for a long time during the procedure, can easily cause damage or infection to the body cavity. The treatment process is complicated and difficult for patients to accept, resulting in a poor experience and even pain, which may ultimately lead to a worsening of the condition and failure to achieve the desired treatment effect.

[0051] Magnetic therapy for hemorrhoids:

[0052] Experimental data: 100 hemorrhoid patients received magnetic therapy with a magnetic field strength of 1.5T (Tesla) and a frequency of 50-80Hz. Each treatment lasted 20-30 minutes. After 5-7 treatments, 72 patients reported that their pain level was reduced by at least 50% compared to before treatment, and 62 patients showed significant reduction in hemorrhoid swelling. The excellent and good rate was 87%.

[0053] Advantages: High safety. Magnetic therapy is a safe treatment method that is non-invasive and painless, and will not cause significant harm or side effects to the human body. There is no risk of infection. For hemorrhoid patients after surgery, magnetic therapy also promotes wound healing and inhibits recurrence.

[0054] Disadvantages: The treatment effect varies from person to person and is not effective for all patients. The treatment effect is relatively slow and takes a certain amount of time to appear. The treatment time is relatively long and usually requires multiple treatments, each of which may take a relatively long time to achieve a good result.

[0055] In summary, electrical stimulation therapy has a high efficacy rate but carries a risk of infection, while magnetic therapy is very safe and does not carry a risk of infection, but its efficacy rate is lower compared to electrical stimulation therapy.

[0056] Therefore, the question of how to provide a hemorrhoid treatment device with a low risk of infection urgently needs to be addressed.

[0057] It needs to be explained that magnetotherapy utilizes artificial magnetic fields (external magnetic fields) applied to the meridians, acupoints, and affected areas of the body to unblock the meridians, promote the flow of Qi, and thus improve local blood circulation to achieve the purpose of treating diseases. Clinical studies have shown that magnetotherapy can achieve analgesia, reduce swelling, reduce inflammation, and promote wound healing by improving tissue nutrition, correcting tissue ischemia and hypoxia, promoting the absorption and dissipation of inflammatory exudates, and decomposing and transforming pain-causing substances. For example, in the paper "Preliminary Exploration of the Clinical Efficacy of Magnetotherapy in the Treatment of Grade II Internal Hemorrhoids",... The study (Gao Shenwang, Su Hongwen. Preliminary study on the clinical efficacy of magnetic therapy in treating grade II internal hemorrhoids [J]. Colorectal and Anal Surgery, 2021, 27(2):145-147, 151.DOI:10.19668 / j.cnki.issn1674-0491.2021.02.011) explored the clinical efficacy of magnetic therapy in treating grade II internal hemorrhoids, using 90 patients with grade II internal hemorrhoids as the research subjects, and showed that magnetic therapy has a therapeutic or alleviating effect on hemorrhoids.

[0058] Based on this, this application provides a magnetic therapy device and magnetic therapy system for treating hemorrhoids with low infection risk, the details of which will be described in subsequent embodiments.

[0059] Please refer to Figures 1 to 4This application provides a magnetic therapy device 10, which is used to perform magnetic therapy on a user. It should be noted that the magnetic therapy device 10 can be used, but is not limited to, in the fields of hemorrhoid magnetic therapy, prostate magnetic therapy, etc. The magnetic therapy device 10 can be a chair, on which the user can sit for magnetic therapy; this type of magnetic therapy device 10 can also be called a magnetic therapy chair. In some embodiments, the magnetic therapy device 10 can also be a recliner or a bed, on which the user can lie down for magnetic therapy; this type of magnetic therapy device 10 can also be called a magnetic therapy bed or magnetic therapy recliner. Of course, regardless of whether the magnetic therapy device 10 is a magnetic therapy chair, a magnetic therapy bed, or a magnetic therapy recliner, it can all be collectively referred to as a magnetic therapy instrument. This application's embodiments are based on a magnetic therapy chair for illustrative purposes.

[0060] The magnetic therapy device 10 includes a support component 11 and a magnetic therapy component 12, which will be described in detail below with reference to the accompanying drawings.

[0061] The support component 11 is used to support other components of the magnetic therapy device 10 and to support the user mounted on the magnetic therapy device 10. The composition of the support component 11 will be described in detail in subsequent embodiments.

[0062] The magnetic therapy component 12 is supported by the support component 11. The magnetic therapy component 12 includes: a support plate 121, a cushion 122, and a magnetic generation component 123.

[0063] The support plate 121 is connected to the support assembly 11. The material of the support plate 121 may be, but is not limited to, acrylonitrile butadiene styrene copolymer (ABS).

[0064] The seat cushion 122 is positioned facing the support plate 121, and is located on the side of the support plate 121 opposite to the support assembly 11, and is supported by the support plate 121. The seat cushion 122 and the support plate 121 together form a receiving space X1. The seat cushion 122 is used to support a user, that is, a user can sit on the seat cushion 122, or in other words, the seat cushion 122 is used to support the user's buttocks. The seat cushion 122 can be made of one material or composed of multiple materials. The material of the seat cushion 122 can be, but is not limited to, acrylonitrile butadiene styrene copolymer (ABS), leather, etc.

[0065] The magnetic generating component 123 is disposed within the receiving space X1. The magnetic generating component 123 includes a coil 1231, which is positioned opposite the seat cushion 122. The coil 1231 generates a high-intensity magnetic field when energized, providing magnetic therapy to the user. Specifically, the pulse width of the high-intensity magnetic field can be between 200-300 μs, the pulse repetition frequency can be between 1-150 Hz, and the magnetic field strength can be between 0.56-3 T.

[0066] Understandably, in the magnetic therapy component 12, the coil 1231 is positioned directly opposite the seat cushion 122. When the user sits on the seat cushion 122, the magnetic field generated by the coil 1231 acts on the user, thereby providing magnetic therapy to improve hemorrhoids or prostatitis. Simultaneously, since the coil 1231 is located within the receiving space X1 formed by the seat cushion 122 and the support plate 121, the coil 1231 is protected and, to a certain extent, isolated from external objects (such as metals that shield magnetic fields), preventing external objects from affecting the magnetic field and weakening the magnetic therapy effect.

[0067] In one embodiment, please refer to Figure 5 , Figure 5 The circuit structure diagram of the magnetizing component provided in the embodiment of this application is shown. The magnetizing component includes: a control circuit 501, an adjustable pulse power supply 502, an RC circuit 503, a MOSFET switching circuit 504, an RLC oscillation circuit 505, a frequency adjustment module 506, a magnetic field feedback module 507, and a physiological parameter detection module 508. The RLC oscillation circuit 505 includes the coil 1231.

[0068] The first terminal of the control circuit 501 is connected to the first terminal of the frequency adjustment module 506; the second terminal of the control circuit 501 is connected to the first terminal of the adjustable pulse power supply 502; the third terminal of the control circuit 501 is connected to the first terminal of the magnetic field feedback module 507; the fourth terminal of the control circuit 501 is connected to the physiological parameter detection module 508; the second terminal of the frequency adjustment module 506 is connected to the first terminal of the MOSFET switching circuit 504; the second terminal of the magnetic field feedback module 507 is connected to the third terminal of the RLC oscillation circuit 505; the second terminal of the adjustable pulse power supply 502 is connected to the first terminal of the RC circuit 503; the second terminal of the RC circuit 503 is connected to the fourth terminal of the MOSFET switching circuit 504; the second terminal of the MOSFET switching circuit 504 is connected to the first terminal of the RLC oscillation circuit 505; the third terminal of the MOSFET switching circuit 504 is connected to the second terminal of the RLC oscillation circuit 505; the third terminal of the RLC oscillation circuit 505 is connected to the second terminal of the magnetic field feedback module 507.

[0069] The RLC oscillation circuit 505 further includes: a first resistor R1 and a first capacitor C1. The first end of the first resistor R1 is connected to the second end of the MOSFET switching circuit 504 as the first end of the RLC oscillation circuit 505. The second end of the first resistor R1 is connected to the first end of the coil 1231. The second end of the coil 1231 is connected to the second end of the first capacitor C1. The second end of the coil 1231 is also connected to the second end of the magnetic field feedback module 507 as the third end of the RLC oscillation circuit 505. The first end of the first capacitor C1 is connected to the third end of the MOSFET switching circuit 504 as the second end of the RLC oscillation circuit 505.

[0070] In a specific embodiment, the control circuit 501 is used to adjust the pulse frequency of the adjustable pulse power supply 502 to generate a first input voltage; the RC circuit 503 is used to filter the first input voltage to obtain a second input voltage; the RLC oscillation circuit 505 is used to generate a magnetic field through the coil 1231 according to the current corresponding to the second input voltage to obtain a target magnetic field; the target magnetic field can be used to treat the user's hemorrhoids.

[0071] The frequency adjustment module 506 is used to adjust the oscillation frequency of the RLC oscillation circuit 505. It can achieve precise adjustment of the magnetic field frequency under the control of the control circuit 501 by changing the value of the capacitor or inductor in the circuit, so as to meet the requirements of different hemorrhoid treatment plans for the magnetic field frequency, because different frequencies of magnetic fields will produce different physiological effects and treatment effects on hemorrhoid tissue.

[0072] The magnetic field feedback module 507 is used to monitor the magnetic field strength, frequency and other parameters generated by the RLC oscillation circuit 505 in real time, and feed this information back to the control circuit 501. The control circuit 501 compares the feedback information with the preset target value, and then makes corresponding adjustments to the adjustable pulse power supply 502, frequency adjustment module 506, MOSFET switching circuit 504, etc., to ensure that the actual generated magnetic field meets the treatment requirements, realize closed-loop control, and improve the accuracy and stability of magnetic therapy.

[0073] The physiological parameter detection module 508 is used to detect the patient's physiological parameters during the magnetic therapy process. These physiological parameters may include at least one of the following: local anal temperature, blood circulation, tissue electrophysiological parameters, etc., without limitation. These parameters reflect the impact of magnetic therapy on the patient's body and the treatment effect, providing real-time information on the patient's physical condition to the control circuit 501. This allows the control circuit 501 to dynamically adjust the magnetic therapy parameters based on the patient's physiological responses, ensuring the safety and effectiveness of the treatment.

[0074] The frequency adjustment module 506 may include a PWM control module or a processor.

[0075] In one embodiment, the magnetic therapy device, during the process of generating a target magnetic field to treat the user, specifically performs the following steps:

[0076] S1. Obtain the user's target disease data;

[0077] S2. Determine the reference magnetic therapy plan corresponding to the target condition data; the reference magnetic therapy plan includes: reference magnetic field strength, reference magnetic field frequency, and reference treatment duration;

[0078] S3. Control the magnetic therapy component to generate a corresponding first magnetic field according to the first magnetic therapy plan, and perform magnetic therapy on the user for a preset duration through the first magnetic field;

[0079] S4. Obtain the user's target feedback information;

[0080] S5. When the target feedback information meets the preset conditions, the first magnetic field is determined to be the target magnetic field, and the user is given magnetic therapy for the reference treatment duration through the target magnetic field.

[0081] S6. When the target feedback information does not meet the preset conditions, the first magnetic field strength and the first magnetic field frequency of the first magnetic field are determined by the magnetic field feedback module.

[0082] S7. Determine the first difference between the first magnetic field strength and the reference magnetic field strength;

[0083] S8. Adjust the PWM control signal of the MOSFET switching circuit according to the first difference and the target feedback information to obtain the target PWM control signal;

[0084] S9. Determine the second difference between the first magnetic field frequency and the reference magnetic field frequency;

[0085] S10. Adjust the pulse frequency of the adjustable pulse power supply according to the second difference and the target feedback information to obtain the target pulse frequency;

[0086] S11. Obtain the user's historical magnetic therapy data;

[0087] S12. Determine the user's target magnetic field tolerance based on the historical magnetic therapy data;

[0088] S13. Determine the target optimization factor corresponding to the target magnetic field tolerance;

[0089] S14. Adjust the reference treatment duration according to the target optimization factor to obtain the target treatment duration;

[0090] S15. Control the adjustable pulse power supply to operate at the target pulse frequency, and control the MOSFET switching circuit to operate through the target PWM control signal to generate the target magnetic field, and perform magnetic therapy on the user for the target treatment duration through the target magnetic field.

[0091] In this embodiment of the application, the target condition data may include at least one of the following: hemorrhoid size, hemorrhoid type, hemorrhoid bleeding frequency, hemorrhoid pain level, etc., which are not limited here. The preset duration can be preset in advance or defaulted, and the preset duration is less than the target treatment duration. The preset conditions can be preset in advance or defaulted, and the preset conditions are used to determine whether the magnetic therapy is effective.

[0092] In a specific embodiment, the magnetic therapy device can communicate with a user terminal to obtain the user's target condition data. For example, the magnetic therapy device can connect to a network and communicate with the user terminal. The user can manually input the condition data into the user terminal, or the user can authorize the user terminal to detect their physical condition. The user terminal obtains the target condition data and then sends it to the magnetic therapy device. Next, a reference magnetic therapy plan corresponding to the target condition data can be determined. Specifically, the target condition data can be the size of hemorrhoids. The reference magnetic therapy plan is determined based on the hemorrhoid size. For example, a preset mapping relationship between hemorrhoid size and magnetic therapy plan can be stored in advance, and the reference magnetic therapy plan corresponding to the hemorrhoid size in the target condition data can be determined based on this mapping relationship. Then, the magnetic therapy components can be controlled to generate a corresponding first magnetic field according to the first magnetic therapy plan, and the user can receive magnetic therapy for a preset duration through the first magnetic field. Specifically, a reference pulse frequency corresponding to the reference magnetic field strength can be determined. For example, a preset mapping relationship between the magnetic field strength and pulse frequency can be stored in advance. The mapping relationship between the magnetic field frequency and the PWM control signal is determined based on this mapping relationship. Then, the reference pulse frequency corresponding to the reference magnetic field frequency can be determined. Similarly, the mapping relationship between the preset magnetic field frequency and the PWM control signal can be stored in advance. Based on this mapping relationship, the reference PWM control signal corresponding to the reference magnetic field frequency is determined, and the adjustable pulse power supply is controlled to work at the reference pulse frequency. The MOSFET switching circuit is controlled to work through the reference PWM control signal to generate the first magnetic field. The user is then given magnetic therapy for a preset duration through the target magnetic field. Then, the user's target feedback information can be obtained. Specifically, the magnetic therapy device can also include a voice module. After the preset duration is over, the user's subjective feelings can be asked through the voice module. For example, open-ended questions such as "How do you feel now?" can be used to allow the user to freely express their feelings, including whether the pain has been relieved, whether the itching has been relieved, whether there is a warm feeling or other abnormal sensations, etc. For example, targeted questions can be asked for specific symptoms. For example, regarding pain, you can ask, "How has your pain level changed compared to before the magnetic therapy? Is it more painful, less painful, or unchanged?" At the same time, users can use a pain rating scale (such as the visual analog scale, where 0 points is no pain and 10 points is severe pain) to quantify the change in pain level. Alternatively, you can use a physiological parameter detection module to detect the user. For example, the physiological parameter detection module can include one of the following: heart rate sensor, temperature sensor, blood pressure sensor, millimeter-wave radar, etc., without limitation, thereby obtaining target feedback information.

[0093] When the target feedback information meets the preset conditions, it means that the magnetic therapy has taken effect. The first magnetic field can be determined as the target magnetic field, and the user can be given magnetic therapy for a reference duration based on the target magnetic field.

[0094] When the target feedback information does not meet the preset conditions, the first magnetic field strength and the first magnetic field frequency of the first magnetic field can be determined by the magnetic field feedback module. Specifically, the magnetic field feedback module may include a Hall sensor and a magnetic field sensor. The Hall sensor detects the first magnetic field strength of the first magnetic field, and the magnetic field sensor detects the first magnetic field frequency of the first magnetic field. Then, the first difference between the first magnetic field strength and the reference magnetic field strength is calculated. Then, the PWM control signal of the MOSFET switching circuit can be adjusted according to the first difference and the target feedback information to obtain the target PWM control signal. Specifically, the PWM control signal of the MOSFET switching circuit at the current moment can be obtained first to obtain the first PWM control signal, and the first P can be determined. The WM control signal corresponds to the first duty cycle. Then, the change value of the first duty cycle can be determined by the first difference. For example, a preset mapping relationship between the difference and the change value of the duty cycle can be stored in advance. Based on this mapping relationship, the change value of the first duty cycle corresponding to the first difference is determined. Further, the first fine-tuning coefficient corresponding to the target feedback information can be determined. Specifically, the target feedback information can be the change value of the pain score. A preset mapping relationship between the score change value and the fine-tuning coefficient can be stored in advance. Based on this mapping relationship, the first fine-tuning coefficient corresponding to the change value of the pain score is determined. The value range of the first fine-tuning coefficient can be -0.2 to 0.2. The change value of the first duty cycle is adjusted by the first fine-tuning coefficient. The calculation formula is as follows:

[0095] Second duty cycle change value = First duty cycle change value * (1 + First fine-tuning coefficient);

[0096] Based on the above formula, the second duty cycle change value can be obtained. Then, the first duty cycle can be adjusted according to the second duty cycle change value. The calculation formula is as follows:

[0097] Second duty cycle = First duty cycle + Change in second duty cycle;

[0098] According to the above formula, the second duty cycle can be obtained. Then, a PWM control signal with the second duty cycle, i.e., the target PWM control signal, can be generated by the frequency adjustment module in the magnetic therapy device. Next, the second difference between the first magnetic field frequency and the reference magnetic field frequency can be calculated. Then, the pulse frequency of the adjustable pulse power supply can be adjusted according to the second difference and the target feedback information to obtain the target pulse frequency. Specifically, the pulse frequency of the adjustable pulse power supply at the current moment can be obtained to obtain the first pulse frequency. Next, the first frequency change value corresponding to the second difference can be determined. For example, a preset mapping relationship between the difference and the frequency change value can be stored in advance. Based on this mapping relationship, the first frequency change value corresponding to the second difference can be determined. Further, the target fine-tuning factor corresponding to the target feedback information can be determined. Specifically, the target feedback information can be the pain score change value. A preset mapping relationship between the score change value and the fine-tuning factor can be stored in advance. Based on this mapping relationship, the target fine-tuning factor corresponding to the pain score change value can be determined. The value range of the target fine-tuning factor can be -0.12 to 0.12. The first frequency change value is adjusted by the target fine-tuning factor. The calculation formula is as follows:

[0099] Second frequency change value = First frequency change value * (1 + target fine-tuning factor);

[0100] Based on the above formula, the second frequency change value can be obtained. Then, the first pulse frequency can be adjusted according to the second frequency change value. The calculation formula is as follows:

[0101] Target pulse frequency = first pulse frequency + second frequency change value;

[0102] Based on the above formula, the target pulse frequency can be obtained; then, the user's historical magnetic therapy data can be obtained. Specifically, historical magnetic therapy data can be obtained from a preset database, which can be used to store all the working data of the magnetic therapy device.

[0103] Then, the user's target magnetic field tolerance can be determined based on historical magnetic therapy data. Specifically, the user's age can be obtained, and a reference magnetic field tolerance can be determined based on the user's age. For example, a pre-stored mapping relationship between age and magnetic field tolerance can be used to determine the reference magnetic field tolerance corresponding to the user's age. Next, the number of historical magnetic therapy sessions received by the user can be determined based on historical magnetic therapy data, and the target interference coefficient corresponding to the number of historical magnetic therapy sessions can be determined. Similarly, a pre-stored mapping relationship between the number of magnetic therapy sessions and the interference coefficient can be used to determine the target interference coefficient corresponding to the number of historical magnetic therapy sessions. The target interference coefficient can range from -0.3 to 0.3. The reference magnetic field tolerance is adjusted based on this target interference coefficient, and the calculation formula is as follows:

[0104] Target magnetic field tolerance = Reference magnetic field tolerance * (1 + Target interference coefficient);

[0105] Based on the above formula, the target magnetic field tolerance can be obtained. Next, the target optimization factor corresponding to the target magnetic field tolerance can be determined. For example, a pre-stored mapping relationship between magnetic field tolerance and optimization factors can be used to determine the target optimization factor corresponding to the target magnetic field tolerance. The value range of the target optimization factor can be -0.25 to 0.25. Then, the reference treatment duration can be adjusted according to the target optimization factor, calculated using the following formula:

[0106] Target treatment duration = Reference treatment duration * (1 + Target optimization factor);

[0107] Based on the above formula, the target treatment duration can be obtained. Finally, the adjustable pulse power supply can be controlled to operate at the target pulse frequency, and the MOSFET switching circuit can be controlled to operate through the target PWM control signal to generate the target magnetic field, and the user can be given magnetic therapy for the target treatment duration through the target magnetic field.

[0108] In this way, by acquiring the user's target condition data, a corresponding reference magnetic therapy plan can be determined based on the specific symptoms of hemorrhoids (such as the degree of bleeding, the extent of hemorrhoid prolapse, and the degree of pain). This provides users with different conditions with the most suitable initial settings for magnetic field strength, frequency, and treatment duration, avoiding a "one-size-fits-all" approach and improving the targeted nature of treatment. In addition, during magnetic therapy, the user's target feedback information can be obtained, and the magnetic field parameters can be adjusted based on this feedback. This dynamic adjustment mechanism allows the treatment to be optimized according to the user's actual feelings and reactions. If the user feedback is good, it means that the current magnetic field parameters are appropriate, and treatment can continue according to the reference treatment duration; if the feedback does not meet the preset conditions, the magnetic field strength and frequency can be quickly adjusted to better adapt to individual differences and changes in the user's condition.

[0109] Please refer to Figure 6 Optionally, the seat cushion 122 may include a hard layer 1221 and a first soft layer 1222, wherein the elastic modulus of the first soft layer 1222 is smaller than that of the hard layer 1221, and the first soft layer 1222 covers the side of the hard layer 1221 facing away from the support plate 121. It is understood that the higher the elastic modulus of a material, the stronger its rigidity and the less prone it is to deformation. Therefore, the smaller the elastic modulus of the first soft layer 1222 compared to the hard layer 1221, the easier the first soft layer 1222 is to deform, thus making the user more comfortable when sitting on the seat cushion 122. The hard layer 1221 may be, but is not limited to, ABS material, and the first soft layer 1222 may be, but is not limited to, leather material.

[0110] Please refer to Figure 6 Optionally, the seat cushion 122 may also include a magnetic field permeable plate 1223. The magnetic field permeable plate 1223 is disposed on the side of the first soft layer 1222 facing the coil 1231 and directly opposite the coil 1231. It is used to isolate the first soft layer 1222 and the coil 1231 to prevent the coil 1231 from contacting the first soft layer 1222 when the user sits on the seat cushion 122. This can protect the first soft layer 1222 and also protect the user's buttocks. The material of the magnetic field permeable plate 1223 may be, but is not limited to, polytetrafluoroethylene (PTFE).

[0111] Please refer to Figure 3 and Figure 4 The support plate 121 and the seat cushion 122 are spaced apart to form the receiving space X1. The magnetizing component 123 is disposed between the support plate 121 and the seat cushion 122, and the magnetizing component 123 is spaced apart from both the support plate 121 and the seat cushion 122. That is, the magnetizing component 123 is spaced apart from both the support plate 121 and the seat cushion 122. It is understood that during the operation of the coil 1231, electrical energy is converted into heat energy. If the heat accumulated on the coil 1231 is not removed in time, the temperature will rise, which may eventually lead to a decrease in magnetic field strength, or even cause safety problems such as damage or burnout of the coil 1231. In this embodiment, the magnetizing component 123 is spaced apart from the support plate 121, which means that there is a certain gap space between the magnetizing component 123 and the support plate 121. This space allows air to circulate, which is beneficial for using air to carry the heat generated by the coil 1231 to the outside. Similarly, the fact that the magnetizing component 123 and the seat cushion 122 are spaced apart means that there is a certain gap between the magnetizing component 123 and the seat cushion 122. This gap allows air to circulate, which is beneficial for using air to carry the heat generated by the coil 1231 to the outside.

[0112] Please refer to Figure 4 and Figure 7The magnetic therapy component 12 further includes a first support member 124, which can be columnar, block-shaped, etc., but this application only illustrates a columnar form. The first support member 124 is disposed within the receiving space X1 and is connected to the seat cushion 122 or the support plate 121. The magnetic generation component 123 further includes a coil holder 1232, and the coil 1231 is disposed within the coil holder 1232. The material of the coil holder 1232 can be, but is not limited to, polyamide 66 (PA66). The coil holder 1232 is connected to the first support member 124 so that the magnetic generation component 123 is suspended between the support plate 121 and the seat cushion 122. That is, the magnetic generation component 123 is connected to the first support member 124 and is suspended between the seat cushion 122 and the support plate 121 by utilizing the first support member 124, so that the magnetic generation component 123 is spaced apart from the seat cushion 122 and the support plate 121. It is understandable that when a user sits on the cushion 122, at least a portion of the user's weight will act directly on the cushion 122, and this weight will be transmitted to the support plate 121 through the cushion 122. This means that there is a force transmission between the cushion 122 and the support plate 121. In this embodiment, the first support member 124 is connected to either the cushion 122 or the support plate 121, but not simultaneously to both. Therefore, the user's weight will not be transmitted to the first support member 124, thus preventing the first support member 124 from bending or breaking under stress and affecting the orientation of the magnetizing component 123. Conversely, since the first support member 124 is not subject to force from the user, its own strength does not need to be too great. That is, the volume of the first support member 124 can be small. For example, the first support member 124 can be designed as a support column with a small diameter. It can be understood that by using a smaller volume first support member 124, the occupation of the first support member 124 in the receiving space X1 can be reduced, thereby avoiding the situation where the air flow in the receiving space X1 is hindered due to the excessive volume of the first support member 124. Therefore, using a smaller volume first support member 124 can facilitate more sufficient contact between the air and the magnetizing component 123, thereby carrying away the heat on the magnetizing component 123.

[0113] Optionally, there may be multiple first support members 124, which are arranged at intervals along the circumference of the coil base 1232 and connected to the magnetizing assembly 123. It is understood that providing multiple spaced first support members 124 can stably support the magnetizing assembly 123, keeping it suspended, without occupying too much housing space X1, thereby ensuring that air can flow smoothly around the magnetizing assembly 123.

[0114] Please refer to Figure 8The coil holder 1232 includes a supporting portion 1232a, a limiting portion 1232b, and a connecting portion 1232c. The supporting portion 1232a, the limiting portion 1232b, and the connecting portion 1232c can be an integral structure. The limiting portion 1232b extends from the outer periphery of the supporting portion 1232a towards the supporting plate 121 and the seat cushion 122, i.e., the limiting portion 1232b is bent and connected to the outer periphery of the supporting portion 1232a. The limiting portion 1232b is arranged around the supporting portion 1232a, thus forming a ring shape. The supporting portion 1232a and the limiting portion 1232b together constitute an accommodating space X2, which is used to accommodate the coil 1231. The supporting part 1232a carries the coil 1231, and the limiting part 1232b restricts the degree of freedom of the coil 1231 to prevent the coil 1231 from detaching from the coil holder 1232 due to shaking. The connecting part 1232c is connected to the supporting part 1232a or the limiting part 1232b, and the connecting part 1232c is fixedly connected to the first support member 124 so that the magnetizing component 123 is carried by the first support member 124, thereby realizing that the magnetizing component 123 is in a suspended state. Further, the supporting part 1232a is provided with a through hole X3, which penetrates the supporting part 1232a in the direction of the supporting plate 121 toward the seat cushion 122, and the through hole X3 connects to the accommodating space X2. This arrangement allows the side of the coil 1231 near the seat cushion 122 and the side of the coil 1231 near the supporting plate 121 to be exposed in the accommodating space X1, which is beneficial for the heat dissipation of the coil 1231.

[0115] Please refer to Figure 9 The magnetic therapy component 12 also includes a fan 125, which is disposed within the receiving space X1 and faces the magnetic generating component 123. The fan 125 is used to increase the airflow velocity within the receiving space X1. The fan 125 can be either an exhaust fan or a blower fan; both types increase the airflow velocity around the magnetic generating component 123, creating forced convection heat exchange between the air and the magnetic generating component 123, thus facilitating heat transfer from the magnetic generating component 123 to the air for dissipation. The number of fans 125 can be, but is not limited to, one, two, three, or four. When there are multiple fans 125, they can be arranged around the magnetic generating component 123. For example, there can be two fans 125, positioned on opposite sides of the magnetic generating component 123.

[0116] Optionally, the support plate 121 is provided with through holes X4 (e.g., Figure 4As shown, the through hole X4 penetrates the support plate 121 in the direction from the seat cushion 122. The number of through holes X4 can be, but is not limited to, one, two, three, four, etc. It can be understood that after the through hole X4 is provided, the external environment can be connected to the receiving space X1 through the through hole X4. In this way, the hot air in the receiving space X1 carrying the heat generated by the magnetizing component 123 can be discharged to the external environment in a timely manner, and fresh air in the external environment can also be replenished into the receiving space X1 in a timely manner, which is conducive to the heat dissipation of the magnetizing component 123.

[0117] Furthermore, the fan 125 can be turned on when the coil 1231 is energized; that is, when the coil 1231 is energized and generates a magnetic field, the fan 125 is turned on to blow or ventilate. Of course, the fan 125 can also be turned on when the temperature of the coil 1231 or the temperature within the containment space X1 reaches a temperature threshold. For example, the magnetic therapy component 12 may also include a processor and a temperature sensor. The temperature sensor is used to sense the temperature, which can be the temperature of the magnetic generation component 123 or the temperature of the air within the containment space X1. The processor is electrically connected to the temperature sensor and the fan 125, and the processor is used to determine whether the temperature sensed by the temperature sensor is greater than the temperature threshold. If it is greater than the temperature threshold, the processor controls the fan 125 to turn on to blow or ventilate. Of course, the timing of the fan 125's activation can also be set in other ways, which will not be listed here.

[0118] Please refer to Figure 4 and Figure 7 The magnetic therapy component 12 also includes a second support member 126, which can be columnar, block-shaped, etc., but this application only illustrates a columnar shape. The material of the second support member 126 can be, but is not limited to, metal (such as aluminum), plastic, etc. The opposite ends of the second support member 126 are respectively connected to the support plate 121 and the seat cushion 122, so that the support plate 121 and the seat cushion 122 are spaced apart. That is, by setting the second support member 126 to support the seat cushion 122, when the user sits on the seat cushion 122, the seat cushion 122 transmits the user's weight to the support plate 121 through the second support member 126. It can be understood that the setting of the second support member 126 not only achieves the separation of the seat cushion 122 and the support plate 121, thereby providing a sufficiently large receiving space X1 for the magnetic generation component 123, but also undertakes the force transmission process, thereby avoiding the first support member 124 from being stressed.

[0119] Optionally, there may be multiple second support members 126, which are spaced apart within the receiving space X1. This arrangement ensures that the seat cushion 122 receives support from the second support members 126 over a large load-bearing range, thereby preventing damage to the seat cushion 122. Furthermore, the spaced arrangement of the second support members 126 facilitates smoother airflow within the receiving space X1, ensuring timely heat dissipation for the magnetizing component 123.

[0120] Please refer to Figure 1 and Figure 2 The magnetic therapy device 10 also includes a backrest 13, which is connected to the magnetic therapy component 12 or the support component 11. The backrest 13 is arranged along the periphery of the magnetic therapy component 12 for the user to lean against. When the user sits on the cushion 122, the user's back can lean against the backrest 13, allowing the user's upper body to relax. Further, the backrest 13 includes a backrest body 131 and a second soft layer 132, wherein the elastic modulus of the second soft layer 132 is smaller than that of the backrest body 131, and the second soft layer 132 covers the side of the backrest body 131 closest to the cushion 122. It can be understood that the smaller elastic modulus of the second soft layer 132 compared to the elastic modulus of the backrest body 131 means that the second soft layer 132 is more easily deformed, thus making it more comfortable for the user to sit on the cushion 122. The backrest body 131 may be, but is not limited to, made of ABS material, and the second soft layer 132 may be, but is not limited to, made of leather material. Please refer to further details. Figure 10 The backrest body 131 includes a backrest portion 1311 and two armrest portions 1312. The backrest portion 1311 is connected to the magnetic therapy component 12 or the support component 11, and the two armrest portions 1312 are respectively connected to both ends of the backrest portion 1311. The backrest portion 1311 is used to support the user's back, and the two armrest portions 1312 are used to support the user's left and right hands.

[0121] In some embodiments, the backrest 13 can be rotatably connected to the magnetic therapy component 12 or the support component 11, meaning the backrest 13 can rotate relative to the magnetic therapy component 12. With this configuration, the user can adjust the tilt angle of the backrest relative to the magnetic therapy component 12 to achieve the desired leaning posture.

[0122] Please refer to Figure 1 and Figure 2The magnetic therapy device 10 also includes a housing 14, which surrounds the magnetic therapy component 12 circumferentially and encloses the magnetic therapy component 12 and the backrest 13. In other words, the housing 14 surrounds the magnetic therapy component 12 and the backrest 13, thus concealing the internal structure of the backrest 13 and the magnetic therapy component 12, increasing aesthetics, and also protecting the magnetic generating component 123 within the magnetic therapy component 12. The housing 14 can be made of, but is not limited to, acrylonitrile butadiene styrene (ABS).

[0123] Optionally, the outer shell 14 includes a first shell 141, a middle shell 142, and a second shell 143. The first shell 141 covers a portion of the outer side of the backrest 13 and a portion of the periphery of the magnetic therapy component 12; the second shell 143 covers a portion of the outer side of the backrest 13 and a portion of the periphery of the magnetic therapy component 12; and the middle shell 142 covers the outer side of the backrest 13. This allows for a relatively complete enclosure of the magnetic therapy component 12 and the backrest 13. Furthermore, the first shell 141, the middle shell 142, and the second shell 143 can be a separate structure, which facilitates independent processing and reduces production costs.

[0124] Please refer to Figure 1 and Figure 2 Optionally, the magnetic therapy component 12 further includes an indicator light 127, which is mounted on the support plate 121. Specifically, the indicator light 127 can be positioned on the side of the support plate 121 opposite to the backrest 13, and sandwiched between the first housing 141 and the second housing 143. The indicator light 127 emits light when powered on, and it can be turned on when the coil 1231 is energized; that is, when the coil 1231 generates a magnetic field, the indicator light 127 emits light. This configuration can indicate to the user that the coil 1231 is in working condition.

[0125] Please refer to Figure 1 and Figure 2The support component 11 includes a motor 111, a base 112, and a surrounding plate 113. The motor 111 is supported by the base 112. One end of the motor 111 away from the base 112 is connected to the magnetic therapy component 12. The motor 111 is used to drive the magnetic therapy component 12 away from or closer to the base 112 in the relative direction between the support plate 121 and the seat cushion 122. The surrounding plate 113 is connected to the base 112 and surrounds the motor 111, thus protecting the motor 111. When the user needs the seat cushion 122 to be higher, the motor 111 can be controlled to drive the magnetic therapy component 12 away from the ground; when the user needs the seat cushion 122 to be lower, the motor 111 can be controlled to drive the magnetic therapy component 12 closer to the ground. In other words, with the motor 111 installed, the user can adjust the height of the seat cushion 122 from the ground according to their needs to suit their sitting posture, thus improving the user experience.

[0126] Please refer to Figure 11 Optionally, the through hole X4 on the support plate 121 includes an air inlet X41 and an air outlet X42, which are spaced apart. The air inlet X41 is positioned directly opposite the coil 1231. The magnetic therapy assembly 12 also includes a guide 128 disposed between the cushion 122 and the support plate 121. The guide 128 has a first opening K5 and a second opening K6 that communicate with each other. The first opening K5 faces the coil 1231, and the second opening K6 faces the air outlet X42 of the support plate 121 to communicate with the air outlet X42. A fan 125 is disposed within the first opening K5 and is used to provide airflow from the air inlet X41 towards the air outlet X42. Figure 11 (The direction indicated by the dashed arrow in the diagram). When the fan 125 is working, the hot air in the housing space X1 is driven by the fan 125 into the guide member 128, and then discharged into the outside environment through the second opening K6 and the air outlet X42 in sequence. Fresh air from the outside environment then enters the housing space X1 through the air inlet X41. It can be understood that after setting the guide member 128, the fan 125 can guide the hot air in the housing space X1 to the outside in a timely manner, avoiding the hot air from constantly filling the housing space X1. In addition, since the air inlet X41 is set directly opposite the coil 1231, the fresh air from the outside entering the housing space X1 through the air inlet X41 can first contact the coil 1231, which is beneficial to the heat dissipation of the coil 1231.

[0127] In summary, the magnetic therapy device 10 provided in this application is equipped with a magnetic therapy component 12, which includes a support plate 121, a seat cushion 122, and a magnetic generating component 123. The coil 1231 of the magnetic generating component 123 is positioned opposite the seat cushion 122 and generates a magnetic field when energized. Therefore, when a user sits on the seat cushion 122, the magnetic field generated by the coil 1231 acts on the user, allowing them to receive magnetic therapy and thus improve hemorrhoid problems. It is understood that using the magnetic therapy device 10 to treat hemorrhoids only requires the user to sit on the device; no complicated operation is needed, and the treatment device (i.e., the magnetic therapy device 10) does not need to be inserted into the body, thus avoiding damage or infection to the body cavity. This reduces the risk of infection during hemorrhoid treatment, improves the safety of hemorrhoid treatment, and also alleviates the pain caused by hemorrhoids. In other words, this application provides a low-risk magnetic therapy device and system for treating hemorrhoids. In addition, since the coil 1231 is located in the receiving space X1 formed by the seat cushion 122 and the support plate 121, the coil 1231 can be protected and external objects can be isolated to a certain extent to avoid external objects affecting the magnetic field and thus weakening the magnetic therapy effect.

[0128] Please refer to Figure 12 This application also provides a magnetic therapy system 1, which includes a host 20 and the magnetic therapy device 10 described in any of the preceding embodiments. Details regarding the magnetic therapy device 10 are provided in the descriptions of the preceding embodiments and will not be repeated here. The host 20 is communicatively connected to the magnetic therapy system 1 to achieve data interaction; this communication connection can be wired or wireless.

[0129] Please refer to Figure 13 The host 20 is equivalent to a control device, used to control the magnetic therapy device 10 to generate a magnetic field. The host 20 may include a controller 21, which is communicatively connected to the magnetic therapy system 1. The controller 21 can control the coils 1231 in the magnetic therapy system 1 to output magnetic fields of different waveforms. Different waveform magnetic fields correspond to different magnetic therapy modes, and different magnetic therapy modes correspond to different magnetic therapy effects.

[0130] In a specific implementation, controller 21 can be used to achieve the following functions:

[0131] The process involves: acquiring target physiological state parameters of a target object; acquiring target case information of the target object; determining the target operating mode of the magnetic therapy system corresponding to the target case information; determining a first operating parameter corresponding to the target operating mode; determining a target optimization parameter corresponding to the target physiological state parameters; optimizing the first operating parameter according to the target optimization parameter to obtain a second operating parameter; controlling the magnetic therapy system to perform magnetic therapy operation with the second operating parameter; during the magnetic therapy operation, acquiring physiological state parameters of the target object within a preset time period to obtain multiple physiological state parameters; determining the increment between two adjacent physiological state parameters among the multiple physiological state parameters to obtain multiple increments; fitting the multiple increments to obtain a fitted straight line; determining the target slope of the fitted straight line; determining the target fine-tuning coefficient corresponding to the target slope; fine-tuning the second operating parameter according to the target fine-tuning coefficient to obtain the target operating parameter; and controlling the magnetic therapy system to perform magnetic therapy operation with the target operating parameter.

[0132] In this embodiment, the target object may include a person or a pet, and the pet may include at least one of the following: cats, dogs, etc., without limitation. The target physiological state parameters may include at least one of the following: blood pressure, blood temperature, adrenaline, blood lipids, blood glucose, etc., without limitation. The target medical information may include at least one of the following: underlying diseases, physical examination data, etc., without limitation. The first operating parameter may include at least one of the following: operating current, operating voltage, operating power, operating frequency (e.g., switching control frequency), magnetic field strength, magnetic field influence range, etc., without limitation.

[0133] In practice, the target physiological state parameters of the target object can be obtained through wearable devices, and the target case information of the target object can be obtained through a networked medical database. The mapping relationship between preset case information and the working mode of the magnetic therapy system can also be stored in advance. Different working modes are used to treat different diseases. Then, the target working mode of the magnetic therapy system corresponding to the target case information can be determined according to the mapping relationship. Different working modes can correspond to different working parameters. For example, a corresponding default working parameter, i.e., the first working parameter, can be set for each working mode. Then, the first working parameter corresponding to the target working mode can be determined according to the preset mapping relationship between working modes and working parameters.

[0134] In addition, physiological state parameters reflect the user's physical condition to a certain extent. For example, if the physical condition is good, the treatment can be strengthened appropriately, and if the physical condition is poor, the treatment can be weakened. In this way, the treatment can be dynamically adjusted based on the user's physical condition, ensuring that the user's body can withstand it and that the treatment effect is optimal within the user's tolerance range. Furthermore, a preset mapping relationship between physiological state parameters and optimization parameters can be set in advance. Then, a target optimization parameter corresponding to the target physiological state parameter can be determined based on this mapping relationship. The first working parameter is then optimized according to the target optimization parameter to obtain the second working parameter. The value range of the optimization parameter can be -0.4 to 0.4. The second working parameter = (1 + target optimization parameter) * first working parameter. The magnetic therapy system is then controlled to perform magnetic therapy operation with the second working parameter.

[0135] Next, during the magnetic therapy procedure, physiological state parameters of the target object can be collected within a preset time period, resulting in multiple physiological state parameters. The preset time period can be pre-set or a system default; for example, the preset time period could be one minute after the start of magnetic therapy. In practice, the physiological state parameters of the target object can be collected at preset time intervals, which can also be pre-set or a system default. Then, the increment between two adjacent physiological state parameters is determined, resulting in multiple increments. Adjacent refers to adjacent sampling times. The specific calculation method for the increment can be to subtract the previous physiological state parameter from the subsequent sampled physiological state parameter to obtain an increment. The time point corresponding to each increment can be the mean time of the sampling time points of the physiological state parameter used to calculate the increment. Then, each increment can be regarded as a coordinate point, with time on the horizontal axis and the increment magnitude on the vertical axis. Multiple increments can then be fitted to obtain a fitted straight line. The target slope of the fitted straight line can also be determined. Different slopes reflect the user's adaptation mood. The magnitude of the slope, to a certain extent, reflects whether the user feels anything and the intensity of that feeling. The slope can be positive or negative. For example, a positive value indicates that the current magnetic therapy is somewhat uncomfortable for the user, while a negative value indicates that the current magnetic therapy is somewhat insensitive to the user. The magnetic therapy system can then be adjusted accordingly. The system works by pre-storing a mapping relationship between a preset slope and a fine-tuning coefficient. Then, a target fine-tuning coefficient corresponding to the target slope can be determined according to this mapping relationship. The fine-tuning coefficient can range from -0.0 to 0.08. The second working parameter can then be fine-tuned based on the target fine-tuning coefficient to obtain the target working parameter: Second working parameter = (1 + Target fine-tuning coefficient) * Second working parameter. Finally, the magnetic therapy system is controlled to perform magnetic therapy operations with the target working parameter. This is equivalent to being able to sensitively capture the user's emotional changes during the magnetic therapy process to identify whether the user is enjoying the treatment. Furthermore, the system dynamically adjusts the working parameters of the magnetic therapy system based on feedback, ensuring that the magnetic therapy effect deeply adapts to the user's actual situation. This helps improve the therapeutic effect of the magnetic therapy system and also enhances the user experience.

[0136] Please refer to Figure 14 The main unit 20 may also include a control panel 22, which allows for operations such as setting magnetic therapy parameters and selecting magnetic therapy modes. The control panel 22 is electrically connected to the controller 21. Users can preset magnetic therapy parameters or select magnetic therapy modes on the control panel 22, and then the controller 21 controls the coil 1231 to output the corresponding magnetic field type based on the magnetic therapy parameters and modes. The control panel 22 may be, but is not limited to, a capacitive touchscreen all-in-one device; that is, the control panel 22 may be a device that integrates a display screen and touch functionality.

[0137] Please refer to Figure 14The host 20 may also include a camera 23, which may be used for user recognition, video calls, etc., to make the interaction between the user and the host 20 more intelligent and convenient. For example, if the control panel 22 does not receive any user operation within a set time range (e.g., 30 seconds), the controller 21 will lock the control panel 22, preventing the user from operating it to avoid accidental operation that could affect the magnetic therapy process. When the user needs to operate the control panel 22, the user can face the camera 23 so that the camera 23 can collect the user's facial data. The controller 21 will then compare the facial data with pre-stored data to determine if the facial data matches the pre-stored data. If they match, the controller 21 will unlock the control panel 22, allowing the user to operate it.

[0138] Please refer to Figure 14 The main unit 20 may also include at least one button 24, the number of which may be, but is not limited to, one, two, three, four, five, etc. The function of the button 24 can be set according to the requirements. For example, there may be two buttons 24, one of which is an emergency stop knob, which is used to stop the main unit 20 from running in an emergency, and the other button 24 is a power switch, which is used to turn the main unit 20 on or off.

[0139] Please refer to Figure 14 The main unit 20 may further include a carrier 25 and a base 26, with the carrier 25 supported by the base 26. The carrier 25 may be an integrated structure of a housing and a frame. The carrier 25 is used to mount the control panel 22, camera 23, buttons 24, etc. The control panel 22 may be located at the end of the carrier 25 away from the base 26, facilitating user operation. The camera 23 may be located on the side of the control panel 22 away from the base 26, allowing it to be aimed at the user's face. Since the buttons 24 are used relatively infrequently, they may be located between the control panel 22 and the base 26. The base 26 may include a base body 261 and a roller 262. The base body 261 is connected to the carrier 25, and the roller 262 is rotatably connected to the end of the base body 261 away from the carrier 25, allowing the user to move the main unit 20 by pushing. The number of rollers 262 can be multiple, and the specific number can be, but is not limited to, 2, 3, 4, etc.

[0140] Please refer to Figure 15 The main unit 20 may also include a pusher 27, which is connected to the carrier 25 and located on the side of the carrier 25 away from the control panel 22. The pusher 27 is provided so that the user can push the main unit 20 by holding the pusher 27.

[0141] Although embodiments of this application have been shown and described above, it is understood that the above embodiments are exemplary and should not be construed as limiting this application. Those skilled in the art can make changes, modifications, substitutions and variations to the above embodiments within the scope of this application, and such improvements and refinements are also considered to be within the protection scope of this application.

Claims

1. A magnetic therapy device, characterized in that, The magnetic therapy device is used to perform magnetic therapy on a user, and the magnetic therapy device includes: Support components; and A magnetic therapy component, which is supported by the support component, includes: A support plate, which is connected to the support assembly; A seat cushion is disposed on the side of the support plate opposite to the support assembly and supported by the support plate. The seat cushion and the support plate together form a receiving space, and the seat cushion is used to support the user. A magnetic generation component is disposed within the receiving space. The magnetic generation component includes a coil positioned directly opposite the seat cushion. The coil is used to generate a magnetic field when energized, so as to provide magnetic therapy to the user through the magnetic field. The magnetizing component includes: a control circuit, an adjustable pulse power supply, an RC circuit, a MOSFET switching circuit, an RLC oscillation circuit, a frequency adjustment module, a magnetic field feedback module, and a physiological parameter detection module. The RLC oscillation circuit includes the coil. The first terminal of the control circuit is connected to the first terminal of the frequency adjustment module; the second terminal of the control circuit is connected to the first terminal of the adjustable pulse power supply; the third terminal of the control circuit is connected to the first terminal of the magnetic field feedback module; the fourth terminal of the control circuit is connected to the physiological parameter detection module; the second terminal of the frequency adjustment module is connected to the first terminal of the MOSFET switching circuit; the second terminal of the magnetic field feedback module is connected to the third terminal of the RLC oscillation circuit; the second terminal of the adjustable pulse power supply is connected to the first terminal of the RC circuit; the second terminal of the RC circuit is connected to the fourth terminal of the MOSFET switching circuit; the second terminal of the MOSFET switching circuit is connected to the first terminal of the RLC oscillation circuit; the third terminal of the MOSFET switching circuit is connected to the second terminal of the RLC oscillation circuit; the third terminal of the RLC oscillation circuit is connected to the second terminal of the magnetic field feedback module. The RLC oscillation circuit further includes: a first resistor and a first capacitor. The first end of the first resistor is connected to the second end of the MOSFET switching circuit as the first end of the RLC oscillation circuit. The second end of the first resistor is connected to the first end of the coil. The second end of the coil is connected to the second end of the first capacitor. The second end of the coil is also connected to the second end of the magnetic field feedback module as the third end of the RLC oscillation circuit. The first end of the first capacitor is connected to the third end of the MOSFET switching circuit as the second end of the RLC oscillation circuit.

2. The magnetic therapy device of claim 1, wherein, The support plate and the seat cushion are spaced apart to form the receiving space, and the magnetizing component is disposed between the support plate and the seat cushion, with the magnetizing component spaced apart from both the support plate and the seat cushion.

3. The magnetic therapy device of claim 1, wherein the magnetic field generator is a permanent magnet. The magnetic therapy component also includes a first support member, which is disposed within the receiving space and connected to the cushion or support plate. The magnetizing assembly further includes a coil holder, the coil is disposed in the coil holder, and the coil holder is connected to the first support member, so that the magnetizing assembly is suspended between the support plate and the cushion.

4. The magnetic therapy device of claim 3, wherein the magnetic field generator is a permanent magnet. The coil holder includes a support portion, a limiting portion, and a connecting portion. The limiting portion extends from the outer periphery of the support portion toward the support plate and toward the seat cushion. The support portion and the limiting portion together form an accommodating space for accommodating the coil. The connecting portion is connected to the support portion or the limiting portion and is fixedly connected to the first support member to support the magnetizing component via the first support member.

5. The magnetic therapy device of claim 1, wherein the magnetic field generator is a permanent magnet. The magnetic therapy component also includes a fan, which is disposed within the containment space and faces the magnetic generating component, and is used to increase the airflow speed within the containment space.

6. The magnetic therapy device of claim 1, wherein the magnetic field generator is a permanent magnet. The magnetic therapy component also includes a second support member, the opposite ends of which are connected to the support plate and the seat cushion, respectively, so that the support plate and the seat cushion are spaced apart.

7. The magnetic therapy device of any one of claims 1 to 6, wherein the magnetic therapy device is a magnetic bracelet. The magnetic therapy device also includes a backrest, which is connected to the magnetic therapy component or the support component. The backrest is arranged along the periphery of the magnetic therapy component for the user to lean against.

8. The magnetic therapy device of claim 7, wherein the magnetic field generator is a permanent magnet. The magnetic therapy device also includes a housing that surrounds the magnetic therapy component circumferentially and encloses the magnetic therapy component and the backrest.

9. The magnetic therapy device of any one of claims 1 to 6, wherein the magnetic therapy device is a magnetic bracelet. The support assembly includes a motor and a base. The motor is supported on the base, and one end of the motor away from the base is connected to the magnetic therapy assembly. The motor is used to drive the magnetic therapy assembly away from or towards the base in the relative direction of the support plate and the cushion.

10. A magnetic therapy system characterised in that, The magnetic therapy system includes a host computer and a magnetic therapy device as described in any one of claims 1 to 9, wherein the host computer is used to control the magnetic therapy device to generate a magnetic field.

Images